Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 7.02%52.95B | 10.40%49.48B | 7.33%14.53B | 12.53%12.69B | 11.86%11.39B | 10.67%10.86B | 15.48%44.82B | 20.17%13.54B | 6.27%11.28B | 14.57%10.19B |
| Cost of revenue | 6.98%40.74B | 8.15%38.08B | 5.83%9.95B | 10.04%10.05B | 9.02%9.34B | 7.79%8.74B | 16.79%35.21B | 20.10%9.4B | 13.10%9.14B | 16.71%8.57B |
| Gross profit | 7.14%12.21B | 18.66%11.4B | 10.75%4.59B | 23.22%2.64B | 26.86%2.05B | 24.36%2.12B | 10.87%9.61B | 20.27%4.14B | -15.52%2.14B | 4.46%1.62B |
| Operating expense | 5.87%8.74B | 13.93%8.25B | 14.12%2.2B | 14.04%2.04B | 12.28%2B | 15.31%2.01B | -13.39%7.24B | -10.95%1.93B | -15.94%1.79B | -13.31%1.78B |
| Operating profit | 10.49%3.48B | 33.15%3.15B | 7.81%2.39B | 69.89%598M | 127.98%47M | 413.89%113M | 687.33%2.36B | 73.10%2.21B | -13.30%352M | 67.12%-168M |
| Net non-operating interest income (expenses) | -20.00%4M | 25.00%5M | 0.00%3M | 0 | 0.00%1M | 1M | 33.33%4M | 0.00%3M | 0 | 0.00%1M |
| Non-operating interest income | 0.00%10M | -9.09%10M | -20.00%4M | 0.00%2M | -33.33%2M | 100.00%2M | 0.00%11M | 0.00%5M | 100.00%2M | 0.00%3M |
| Non-operating interest expense | 20.00%6M | -28.57%5M | -50.00%1M | 0.00%2M | -50.00%1M | 0.00%1M | -12.50%7M | 0.00%2M | 0.00%2M | 0.00%2M |
| Net investment income | 41.77%112M | 12.86%79M | 33.33%4M | 19.35%37M | 25.00%5M | 3.13%33M | -1.41%70M | 0.00%3M | 10.71%31M | 33.33%4M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 77.78%-16M | -28.57%-72M | 77.78%-10M | -229.41%-56M | -45M | |||||
| Income from associates and other participating interests | 383.33%17M | -115.38%-6M | -33.65%69M | 72.34%-13M | -5.56%-19M | -43M | 85.71%39M | 10.64%104M | -1,040.00%-47M | 61.70%-18M |
| Special income (charges) | -91.53%-113M | 18.06%-59M | -14.81%-62M | 300.00%12M | 960.00%43M | -642.86%-52M | -103.08%-72M | -102.13%-54M | -50.00%-6M | 97.13%-5M |
| Less:Other special charges | 957.14%60M | -158.33%-7M | 66.67%-2M | -300.00%-12M | -1,000.00%-45M | 642.86%52M | 100.44%12M | 99.78%-6M | 500.00%6M | 150.00%5M |
| Less:Write off | -19.70%53M | 10.00%66M | 6.67%64M | --0 | --2M | --0 | -84.17%60M | -67.74%60M | --0 | --0 |
| Other non-operating income (expenses) | 3.31%156M | -30.41%151M | 142.86%68M | -28.57%40M | -46.67%16M | -73.79%27M | -70.27%217M | -61.64%28M | -77.69%56M | -88.42%30M |
| Income before tax | 12.06%3.63B | 26.33%3.24B | 8.95%2.46B | 63.64%612M | 160.90%95M | -16.30%77M | -25.49%2.57B | -43.11%2.26B | -45.32%374M | 66.60%-156M |
| Income tax | 17.37%1.16B | 23.75%990M | -13.00%562M | 138.38%236M | 1,090.91%109M | 25.76%83M | -38.84%800M | -50.87%646M | -30.28%99M | 82.81%-11M |
| Net income | 9.72%2.47B | 27.45%2.25B | 17.75%1.9B | 36.00%374M | 90.97%-13M | -124.00%-6M | -17.31%1.77B | -39.25%1.61B | -49.26%275M | 64.27%-144M |
| Net income continuous operations | 9.72%2.47B | 27.50%2.25B | 17.75%1.9B | 36.73%376M | 90.34%-14M | -123.08%-6M | -17.31%1.77B | -39.25%1.61B | -49.26%275M | 64.02%-145M |
| Noncontrolling interests | 0 | 0 | 0 | 0 | 0 | 0 | -1M | 0 | -1M | 0 |
| Net income attributable to the company | 9.77%2.47B | 27.46%2.25B | 17.62%1.9B | 37.36%375M | 90.28%-14M | -124.00%-6M | -17.36%1.77B | -39.22%1.61B | -49.63%273M | 64.27%-144M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 9.77%2.47B | 27.46%2.25B | 17.62%1.9B | 37.36%375M | 90.28%-14M | -124.00%-6M | -17.36%1.77B | -39.22%1.61B | -49.63%273M | 64.27%-144M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 9.68%204.945 | 27.42%186.86 | 17.63%157.38 | 36.52%31.14 | 90.91%-1.1 | -126.17%-0.56 | -17.36%146.65 | -39.25%133.795 | -49.32%22.81 | 63.87%-12.095 |
| Diluted earnings per share | 9.68%204.945 | 27.42%186.86 | 17.60%157.3373 | 37.27%31.117 | 90.40%-1.1617 | -126.17%-0.56 | -17.36%146.65 | -39.24%133.795 | -49.63%22.6686 | 63.87%-12.095 |
| Dividend per share | 50.00%30 | 14.29%20 | 28.57%11.25 | 0 | 0.00%8.75 | 0 | 0.00%17.5 | 0.00%8.75 | 0 | 0.00%8.75 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |